Roxicodone and Ibrance drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Roxicodone (oxycodone hydrochloride) and Ibrance (palbociclib). Common drug interactions include metastases to spine among females and facial paralysis among males.

The phase IV clinical study analyzes what interactions people have when they take Roxicodone and Ibrance. It is created by eHealthMe based on reports of 44 people who take the same drugs from the FDA, and is updated regularly.

What is Roxicodone?

Roxicodone has active ingredients of oxycodone hydrochloride. It is often used in pain. eHealthMe is studying from 20,099 Roxicodone users. Check the latest studies of Roxicodone.

What is Ibrance?

Ibrance has active ingredients of palbociclib. eHealthMe is studying from 104,434 Ibrance users. Check the latest studies of Ibrance.

eHealthMe: drug outcomes in the real world

eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.

On Aug, 31, 2026

44 people who take Roxicodone and Ibrance together, and have interactions are studied.

Roxicodone and Ibrance drug interactions.

What are the common drug interactions of Roxicodone and Ibrance, by gender? *:

female:

Metastases to spine (cancer spreads to spine)
Neutropenia (an abnormally low number of neutrophils)
Neutrophil count decreased (less than normal number of neutrophil a type of blood cell)
Oedema (fluid collection in tissue)
Oxygen saturation decreased
Panic attack
Platelet count decreased
Pleural effusion (water on the lungs)
Pulmonary embolism (blockage of the main artery of the lung)
Pulmonary mass

male:

Facial paralysis (loss of function of face muscle)
Balance disorder
Joint stiffness
Loss of consciousness
Memory impairment
Neutrophil count decreased (less than normal number of neutrophil a type of blood cell)
Orthostatic hypotension (a medical condition consisting of a sudden decrease in blood pressure when a person stands up)
Peripheral swelling
Pollakiuria (abnormally frequent passage of relatively small quantities or urine)
Sleep disorder

What are the common drug interactions of Roxicodone and Ibrance, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

n/a

40-49:

Dyspnoea (difficult or laboured respiration)
Hypoaesthesia (reduced sense of touch or sensation)
Pruritus (severe itching of the skin)
Swelling
Neoplasm progression (growth of tumour)
Anxiety
Arthritis (form of joint disorder that involves inflammation of one or more joints)
Autonomic nervous system imbalance (autonomic nervous system is of net equal emphasis)
Blood albumin decreased
Blood chloride decreased

50-59:

Fatigue (feeling of tiredness)
Abdominal pain upper
Acute myocardial infarction (acute heart attack)
Dyspnoea (difficult or laboured respiration)
Full blood count decreased
Nausea (feeling of having an urge to vomit)
Stomatitis (inflammation of mucous membrane of mouth)
Vision blurred
Asthenia (weakness)
Cervical vertebral fracture

60+:

Fatigue (feeling of tiredness)
Neoplasm progression (growth of tumour)
Dizziness postural
Ear pain
Fall
Gait disturbance
Hand fracture
Hypotension (abnormally low blood pressure)
Joint stiffness
Loss of consciousness

What are the existing conditions these people have? *

Breast Cancer Metastatic: 11 people, 25.00%
Nausea (feeling of having an urge to vomit): 9 people, 20.45%
Breast Cancer: 8 people, 18.18%
Breast Cancer Female: 7 people, 15.91%
Nausea And Vomiting: 5 people, 11.36%
Cough: 5 people, 11.36%
Stress And Anxiety: 4 people, 9.09%
Malignant Pituitary Tumor: 4 people, 9.09%
Cancer Pain: 4 people, 9.09%
Rickets (softening of bones): 3 people, 6.82%

* Approximation only. Some reports may have incomplete information.

Do you take Roxicodone and Ibrance?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously